RR
Roanna Ruiz Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
9
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
88.9%
Neutral
11.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $2 |
15%
downside
| 1 | +178% |
0
%
| 17 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $9 |
11%
upside
| 3 | +28% |
0
%
| 19 Aug ‘25 4 months ago |
|
|
|
Outperform
Initiated
| $7 |
370%
upside
| 1 | -37% |
0
%
| 28 Apr ‘25 8 months ago |
|
|
|
Outperform
Initiated
| $18 |
140%
upside
| 1 | -21% |
0
%
| 7 Mar ‘25 10 months ago |
|
|
|
Market Perform
Downgraded
| $1 |
15%
downside
| 1 | – |
–
| 4 Mar ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $20 |
236%
upside
| 1 | -51% |
0
%
| 13 Jan ‘25 1 year ago |
|
|
|
Outperform
Maintained
| $27 |
147%
upside
| 1 | -2.6% |
0
%
| 13 Jan ‘25 1 year ago |
|